3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Neoplasms
3
Febrile Neutropenia
3
Prostatic Neoplasms
2
Neutropenia
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Pancreatic Cyst
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myeloid, Acute
1
Infections
1
Hematologic Neoplasms
1
Early Stage Breast Cancer
1
Cysts
1
Cystectomy
1
Breast Neoplasms
1
Interventions
Filgrastim
2
Ciprofloxacin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Early Stage Breast Cancer
×
Ciprofloxacin
×
Clear all
NCT02816112
2020-05-27
REaCT-TC2
Ottawa Hospital Research Institute
Phase 4
Completed
458 enrolled